Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions

Myelodysplastic syndromes (MDS) comprise a heterogeneous group of myeloid neoplasms characterized by peripheral cytopenia, dysplasia, and a variable clinical course with about 30% risk to transform to secondary acute myeloid leukemia (AML). In the past 15 years, diagnostic evaluations, prognosticati...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Oncotarget
Κύριοι συγγραφείς: Valent, Peter, Orazi, Attilio, Steensma, David P., Ebert, Benjamin L., Haase, Detlef, Malcovati, Luca, van de Loosdrecht, Arjan A., Haferlach, Torsten, Westers, Theresia M., Wells, Denise A., Giagounidis, Aristoteles, Loken, Michael, Orfao, Alberto, Lübbert, Michael, Ganser, Arnold, Hofmann, Wolf-Karsten, Ogata, Kiyoyuki, Schanz, Julie, Béné, Marie C., Hoermann, Gregor, Sperr, Wolfgang R., Sotlar, Karl, Bettelheim, Peter, Stauder, Reinhard, Pfeilstöcker, Michael, Horny, Hans-Peter, Germing, Ulrich, Greenberg, Peter, Bennett, John M.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Impact Journals LLC 2017
Θέματα:
Priority Review
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5650276/
https://ncbi.nlm.nih.gov/pubmed/29088721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19008
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια